13F HOLDINGS REPORT
Ally Bridge Group (NY) LLC
Quarter ended Q2 2024 · Filed August 14, 2024 · Accession 0000950123-24-008408
Total Value
$167.9M
Positions
25
Other Managers
1
Confidential Omitted
No
Holdings (25)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SOLENO THERAPEUTICS INC | SLNO | 286,162 | $11.7M | 6.96% |
| 2 | SAREPTA THERAPEUTICS INC | SRPT | 73,500 | $11.6M | 6.92% |
| 3 | GERON CORP | GERN | 2,736,663 | $11.6M | 6.91% |
| 4 | MERUS N V | N5749R100 | 174,844 | $10.3M | 6.16% |
| 5 | INSMED INC | INSM | 129,000 | $8.6M | 5.15% |
| 6 | LEGEND BIOTECH CORP | LEGN | 195,000 | $8.6M | 5.15% |
| 7 | ALUMIS INC | ALMS | 618,750 | $8.2M | 4.90% |
| 8 | BLUEPRINT MEDICINES CORP | 09627Y109 | 75,638 | $8.2M | 4.86% |
| 9 | DISC MEDICINE INC | IRON | 166,500 | $7.5M | 4.47% |
| 10 | DAY ONE BIOPHARMACEUTICALS I | DAWN | 536,095 | $7.4M | 4.40% |
| 11 | MIND MEDICINE MINDMED INC | 60255C885 | 965,426 | $7.0M | 4.15% |
| 12 | XENON PHARMACEUTICALS INC | XENE | 169,369 | $6.6M | 3.93% |
| 13 | PRAXIS PRECISION MEDICINES I | PRAX | 153,379 | $6.3M | 3.78% |
| 14 | KURA ONCOLOGY INC | KURA | 306,762 | $6.3M | 3.76% |
| 15 | AVADEL PHARMACEUTICALS PLC | G29687103 | 430,245 | $6.0M | 3.60% |
| 16 | LONGBOARD PHARMACEUTICALS IN | 54300N103 | 218,981 | $5.9M | 3.53% |
| 17 | CG ONCOLOGY INC | CGON | 174,876 | $5.5M | 3.29% |
| 18 | JASPER THERAPEUTICS INC | JSPRW | 218,614 | $5.0M | 2.96% |
| 19 | TREVI THERAPEUTICS INC | TRVI | 1,474,926 | $4.4M | 2.62% |
| 20 | TYRA BIOSCIENCES INC | TYRA | 264,660 | $4.2M | 2.52% |
| 21 | PERSPECTIVE THERAPEUTICS INC | CATX | 396,242 | $4.0M | 2.35% |
| 22 | BLACK DIAMOND THERAPEUTICS I | BDTX | 835,000 | $3.9M | 2.32% |
| 23 | CONTEXT THERAPEUTICS INC | CNTX | 1,886,232 | $3.8M | 2.25% |
| 24 | ELIEM THERAPEUTICS INC | CLYM | 500,000 | $3.6M | 2.12% |
| 25 | PROMIS NEUROSCIENCES INC | PMN | 1,059,582 | $1.6M | 0.95% |